IRIS
BONATI, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.874
EU - Europa 1.518
AS - Asia 974
AF - Africa 28
OC - Oceania 2
SA - Sud America 1
Totale 4.397
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.826
CN - Cina 708
IE - Irlanda 314
SE - Svezia 274
IT - Italia 240
FI - Finlandia 235
UA - Ucraina 213
DE - Germania 176
SG - Singapore 122
TR - Turchia 101
CA - Canada 48
CI - Costa d'Avorio 27
GB - Regno Unito 20
JP - Giappone 18
BE - Belgio 14
IN - India 12
AT - Austria 10
NL - Olanda 6
CZ - Repubblica Ceca 5
IR - Iran 4
KR - Corea 4
ES - Italia 3
TW - Taiwan 3
BG - Bulgaria 2
HK - Hong Kong 2
RO - Romania 2
AU - Australia 1
BR - Brasile 1
CH - Svizzera 1
EE - Estonia 1
FR - Francia 1
LU - Lussemburgo 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
Totale 4.397
Salva come PNG Salva come JPEG
Città #
Chandler 333
Jacksonville 322
Dublin 313
Beijing 188
Nanjing 113
Ann Arbor 105
Boardman 99
Izmir 91
Singapore 89
Parma 88
Dearborn 87
Ashburn 76
Princeton 71
San Mateo 71
Jinan 47
Wilmington 47
Toronto 46
Hebei 41
Shenyang 39
Shanghai 31
Des Moines 30
Nanchang 29
Abidjan 27
Kunming 27
Helsinki 24
Hefei 20
Düsseldorf 18
New York 18
Tokyo 18
Woodbridge 17
Bologna 15
Changsha 15
Tianjin 15
Brussels 14
Santa Clara 14
Guangzhou 13
Falls Church 12
Zhengzhou 12
Fremont 11
Grafing 11
Kocaeli 10
Taizhou 10
Haikou 9
Jiaxing 9
Leawood 9
Los Angeles 9
Vienna 9
Fuzhou 8
Lanzhou 8
Milan 8
Seattle 8
Bremen 7
Hangzhou 7
Redmond 7
Trezzano Sul Naviglio 7
Borås 6
Chengdu 6
Houston 6
Taiyuan 6
Ningbo 5
Redwood City 5
Verona 5
Dallas 4
Langhirano 4
Mestre 4
Munich 4
Novara 4
Savignano Sul Rubicone 4
Amsterdam 3
Auburn Hills 3
Chongqing 3
London 3
Modena 3
Mountain View 3
Piacenza 3
Pune 3
Reggio Nell'emilia 3
San Felice Sul Panaro 3
Suwon 3
Taipei 3
Xian 3
Ardabil 2
Arzano 2
Brno 2
Cambridge 2
Cremona 2
Fairfield 2
Focsani 2
Gurgaon 2
Guwahati 2
Inzago 2
Madrid 2
Marghera 2
Miami 2
Monmouth Junction 2
Mumbai 2
Olomouc 2
Padova 2
Phoenix 2
Providence 2
Totale 2.922
Salva come PNG Salva come JPEG
Nome #
Functional interplay between NIK and c-Abl kinases limits response to Aurora inhibitors in multiple myeloma 201
MEK-INHIBITORS/ARSENIC TRIOXIDE COMBINATION THERAPY AS A NOVEL TREATMENT OPTION FOR TYROSINE KINASE INHIBITORS-RESISTANT PH+-LEUKEMIA 124
Lung cancer in patients with chronic lymphocytic leukemia: does the HER-2 oncogene play a role? 85
Treatment with Arsenic Trioxide (ATO) and MEK1 inhibitor activates the p73-p53AIP1 apoptotic pathway in leukemia cells 82
Elevated telomerase activity, minimal telomere loss in cord blood long-term cultures with extensive stem cell replication 77
Selection of myeloid progenitors lacking BCR/ABL mRNA in chronic myelogenous leukemia patients after in vitro treatment with the tyrosine kinase inhibitor genistein. 75
Pan-aurora kinase inhibitor MK-0457 synergistically potentiates Apo2l/TRAIL cytotoxicity in Multiple Mieloma cells sensitive and resistant to bortezomib 72
Early proinflammatory activation of renal tubular cells by normal and pathologic IgG 70
Ph1-positive acute myelocytic leukemia with high TdT levels. 70
Terminal deoxynucleotidyl transferase (TdT) levels in hairy cell leukemia. 69
Acenaphthenequinone thiosemicarbazone and its transition metal complexes: synthesis, structure, and biological activity. 69
Biochemical, Immunological, and Molecular Markers of Hemopoietic Precursor Cells. 68
Downmodulation of ERK protein kinase activity inhibits VEGF secretion by human myeloma cells and myeloma-induced angiogenesis 67
T cell receptor genes: a glance at normal and malignant hematopoiesis. 67
BCL2 oncogene protein expression in human hematopoietic precursors during fetal life. 66
Expression and activation of SHC/MAP kinase pathway in primary acute myeloid leukemia blasts. 65
Arsenic Trioxide (ATO) and MEK1 inhibition synergize to induce apoptosis in acute promyelocytic leukemia cells 65
Human T-cell receptor alpha chain gene during ontogeny 64
Combined treatment with the MEK inhibitor PD0325901 and Arsenic Trioxide has potent anti-tumor activity in vivo against human multiple myeloma xenograft model. 64
The new tumor suppressor gene inhibitor of growth family member 4 (ING4) regulates the production of pro-angiogenic molecules by myeloma cells and suppresses hypoxia inducible factor (HIF)-1{alpha} activity being involved in myeloma-induced angiogenesis. 64
Arsenic Trioxide in hematological malignancies: the new discovery of an ancient drug. 63
T-cell receptor beta-chain gene rearrangement and expression during human thymic ontogenesis. 63
Espressione degli antigeni CD1a, CD1b, CD1c in timo umano a diverse eta' dello sviluppo. 63
Aurora and IKK kinases cooperatively interact to protect multiple myeloma cells from Apo2L/TRAIL 63
MDM2 inhibition synergistically enhances cytotoxicity of MEK1 inhibitor and Arsenic Trioxide (ATO) in AML blasts that retain a functional p53 pathway 61
Contributions of the Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways to leukemia 61
MEK-ERK pathway is expressed but not activated in high proliferating, self-renewing cord blood hematopoietic progenitors 60
Synthesis, spectroscopic characterization and biological properties of new natural aldehydes thiosemicarbazones 60
Emerging MEK inhibitors 60
p73 and p53 pathway in human breast cancers. 60
Synthesis, characterisation, X-ray structure and biological activity of three new 5-formyluracil thiosemicarbazone complexes 60
Su di un caso di sclerodermia associato ad aplasia midollare globale. 59
Expression of TCR beta chain gene N-diversity is not an early event in human thymic ontogeny 58
Effect of the protein tyrosine kinase inhibitor genistein on normal and leukaemic haemopoietic progenitor cells. 58
Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging. 58
The fine structure of HNK-1 (Leu7) positive cells. A study using an immunoperoxidase technique. 57
Terminal deoxynucleotidyl transferase: a nuclear marker of hemopoietic precursors. Biochemical, immunological and clinical aspects. 57
Emerging Raf inhibitors 56
Detection of the common acute lymphoblastic leukaemia antigen (CALLA) on B cells from human fetal tissues. A multiple phenotypic characterization. 56
Expression of the T1 (CD5, p67) surface antigen in B-CLL and B-NHL and its correlation with other B-cell differentiation markers. 56
Role of GSTP1-1 in mediating the effect of As2O3 in the Acute Promyelocytic Leukemia cell line NB4. 56
Downmodulation of ERK activity inhibits the proliferation and induces the apoptosis of primary acute myelogenous leukemia blasts 56
Synthesis, structure, spectroscopic properties and biological activity of mixed diorganotin(IV) complexes containing pyridine-2-carbaldehyde thiosemicarbazonato and diphenyldithiophosphinato ligands. 54
La linfoadenopatia angio-immunoblastica: Osservazioni cliniche, patologiche ed immunologiche su di un caso. 54
MEK1/2 regulate normal BCR and ABL1 tumor-suppressor functions to dictate ATO response in TKI-resistant Ph+ leukemia 53
MEK1/2 KINASES DISABLE THE TUMOR SUPPRESSOR FUNCTIONS OF NATIVE BCR AND ABL1 KINASES TO IMPAIR ANTICANCER DRUGS’ RESPONSIVENESS IN TKI-RESISTANT PHILADELPHIA POSITIVE LEUKEMIAS 53
MEK1 inhibition sensitizes primary acute myelogenous leukemia to arsenic trioxide-induced apoptosis 53
La mielofibrosi idiopatica asplenomegalica. Osservazioni cliniche e considerazioni su cinque casi. 53
Discordant expression of terminal transferase and T cell receptor beta chain in fetal and pediatric thymocytes. 52
Phenotype of the terminal transferase-positive cells in human foetal liver and bone-marrow: analysis with monoclonal antibodies. 52
TCR beta chain expression during human thymic development. 52
Valutazione dell'attivita proliferativa delle cellule emopoietiche nelle sindromi preleucemiche. 51
Hemopoiesis during human fetal life. Present knowledge and future prospects. 50
Terminal deoxynucleotidyl transferase in human fetal tissues. 50
Targeting the cancer initiating cell: the ultimate target for cancer therapy. 49
Terminal deoxynucleotidyl transferase-positive B cell precursors in fetal lymph nodes and extrahemopoietic tissues. 48
Philadelphia-positive chronic myelogenous leukemia with typical bcr/abl molecular features and atypical, prolonged survival. 48
Terminal deoxynucleotidyl transferase (TDT) expression correlates with the presence of N regions during human thymic ontogeny 47
Phorbol ester-induced PKC{epsilon} down-modulation sensitizes AML cells to TRAIL-induced apoptosis and cell differentiation. 47
Terminal deoxynucleotidyl transferase (TdT) in human foetuses. An immunofluorescent and biochemical study. 47
Medicina molecolare: nuovi strumenti per la conoscenza e la cura delle patologie dell'uomo. 46
Selective Expression and Constitutive Phosphorylation of SHC Proteins in the CD34+ Fraction of Chronic Myelogenous Leukemias. 45
Leu-7-positive cells with monocyte phenotype show different ultrastructural features in comparison to Leu-7-positive cells with T-cell phenotype. 45
The combination of MEK inhibitors and Arsenic Trioxide triggers in vitro and in vivo synergistic cytotoxicity in multiple myeloma through multiple signaling pathways 44
Targeting the Raf/MEK/ERK pathway with small-molecule inhibitors. 44
Progression of a myelodysplastic syndrome to pre-B acute lymphoblastic leukaemia with unusual phenotype. 44
Targeting MEK/MAPK signal transduction module potentiates ATO-induced apoptosis in multiple myeloma cells through multiple signaling pathways 43
The p53 family protein p73 provides new insights into cancer chemosensitivity and targeting. 41
A micro-mechanically motivated model for the strength of heat-treated glass 40
Targeting survival cascades induced by activation of Ras/Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways for effective leukemia therapy. 39
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR inhibitors: rationale and importance to inhibiting these pathways in human health. 39
Regulation of proliferation and cytokine expression of bone marrow fibroblasts: role of c-myb. 35
Combined treatment with the MEK inhibitor PD0325901 and Arsenic Trioxide has potent antitumor activity in NOD-SCID mice bearing advanced tumors of human multiple myeloma. 34
MEK-INHIBITORS/ARSENIC TRIOXIDE COMBINATION THERAPY AS A NOVEL TREATMENT OPTION FOR TYROSINE KINASE INHIBITORS-RESISTANT PH plus -LEUKEMIA 32
null 30
Calibration of the Statistical-Interference Factors for the Design of Tempered Structural Glass 22
Totale 4.421
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.711
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.711
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020767 0 0 73 10 79 75 105 12 77 230 28 78
2020/2021499 2 70 37 3 82 17 35 13 111 19 101 9
2021/2022382 5 10 0 14 12 16 63 72 20 34 18 118
2022/20231.178 139 124 94 87 106 123 5 69 379 14 30 8
2023/2024407 33 47 17 8 55 68 24 9 15 23 34 74
2024/2025251 60 92 99 0 0 0 0 0 0 0 0 0
Totale 4.421